Latest Biotech News

Key regulatory developments are impacting biotech and healthcare landscapes. The FDA announced daily publication of adverse event reports, enhancing transparency and post-market safety...

Innovations targeting energy storage efficiency and longevity have emerged prominently. Researchers at University of Ottawa entered the betavoltaic battery commercialization space, promising...

Researchers have revealed unprecedented genetic diversity within early human placentas, challenging traditional views in placental biology. Published in Nature Communications, this study enhances...

A CRISPR screen has identified the histone methyltransferase SUV39H2 as a key mediator of resistance to oncolytic herpes simplex virus 1 (oHSV-1) in oral squamous cell carcinoma (OSCC). This...

Artificial intelligence has facilitated discovery of Bufalin as a molecular glue degrader targeting estrogen receptor alpha (ERα), crucial in many hormone-driven cancers. Published in Nature...

A highly personalized liquid biopsy assay called MRD4U offers unprecedented sensitivity for tracking central nervous system tumors in children. Set to improve early detection and therapeutic...

Recent innovations include defect-engineered BiFe1−xInxO3 nanoparticles enhancing supercapacitor electrodes and MOF-enhanced Sn-doped V2O5 cathodes improving lithium-ion storage. Separately,...

Integration of deep learning with multiparametric MRI has enabled precise prediction of perineural invasion in prostate cancer, advancing oncological imaging. Meanwhile, acquisition of Paige...

The FDA initiated daily publication of adverse event reports to enhance drug safety surveillance, a shift from the previous quarterly updates. Separately, Ionis Pharmaceuticals gained FDA approval...

Kriya Therapeutics raised $313 million to advance gene therapies across ophthalmic, metabolic, and neurological diseases, continuing robust investment in chronic disease treatment. LB...

Recent studies reveal lymphoma accelerates aging in immune cells and tissues, illuminating cancer's broader systemic effects. Additionally, new findings identify regulatory T cells expressing a...

In neurodegeneration, hemoglobin’s antioxidant function within brain astrocytes has been illuminated, offering new therapeutic avenues. Furthermore, brain imaging studies challenge prior beliefs...

The U.S. Food and Drug Administration has begun daily publication of adverse event reports tied to drugs and biological products, enhancing post-market safety surveillance. This shift from...

Artificial intelligence is significantly advancing cancer research and patient care. Uppsala University researchers developed AI models that detect prostate cancer cases missed by pathologists by...

New studies are shedding light on neurodegenerative disorders and potential therapeutic targets. Researchers revealed a brain-delivered antibody that targets alpha-synuclein aggregates implicated...

Ionis Pharmaceuticals secured FDA approval for Dawnzera (donidalorsen), an antisense therapy preventing attacks in hereditary angioedema (HAE), a rare genetic disease. The drug markedly reduces...

Biopharma companies are actively securing capital to advance therapeutic pipelines. Kriya Therapeutics closed a $313 million funding round focused on gene therapies addressing chronic diseases...

Recent studies provide molecular insights and novel therapies across multiple cancer types. Research reveals that the circular RNA circ_0000847 promotes colorectal cancer metastasis via IGF2BP2...

Cutting-edge technologies continue to redefine biotech and diagnostics. Researchers introduced a time-deterministic cryo-optical microscopy technique, bridging temporal precision with cryogenic...

Emerging research enhances understanding of immune regulation and cancer immunotherapy. A novel genome-wide CRISPR screen in human natural killer cells identified key genetic regulators to improve...